No profile data available.
vTv Therapeutics Inc. (VTVT) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in High Point, United States, with about 26 full-time employees.
It reported revenue of $0 for fiscal year 2025, down 100.0% from fiscal year 2024, and net income of -$26.97 million. Its market capitalization was $123.28 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases.
vTv Therapeutics reported $0 in revenue for fiscal year 2025, down 100.0% from $1.02 million in fiscal year 2024.
$123.28 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Tiziana Life Sciences Ltd (TLSA), Korro Bio, Inc. (KRRO), Avidity Biosciences, Inc. (RNA), Vivani Medical, Inc. (VANI).